Ritlecitinib powder

Xi'an Faithful BioTech Co., Ltd: Your Trusted Ritlecitinib powder Manufacturer & Supplier

Xi'an Faithful BioTech Co., Ltd provides customers with stable supply guarantee of Ritlecitinib powder. We are a professional company engaged in the supply of innovative drugs, improved new drugs, generic drugs, active pharmaceutical ingredients and intermediates, integrating resources, controlling quality, and serving customers in major regions around the world with dedication. Your recognition is our greatest pride.

Ritlecitinib powder Introduction

Ritlecitinib powder (CAS: 1792180-81-4) is a white to off white solid powder that belongs to the highly selective JAK3 and TEC kinase family irreversible inhibitors. As a new generation of covalent kinase inhibitors, it specifically blocks the JAK3 signaling pathway, precisely regulates immune system activity, and demonstrates significant therapeutic potential in the field of autoimmune diseases. Our Ritlecitinib powder undergoes strict screening and control from raw materials to workshop production, with advanced production equipment introduced to produce high-quality products that comply with pharmacopoeia.

Specifications

Application area of Ritlecitinib powder

• The core active ingredient of Ritlecitinib formulation is used to treat severe alopecia areata in adolescents and adults aged 12 and above. It is currently the first and only oral drug targeting this target that covers adolescent patients.
• In the research of immune-mediated diseases such as vitiligo and ulcerative colitis, due to their high selectivity for JAK3/TEC, they have significant advantages over pan JAK inhibitors in reducing off target toxicity.
• It can also be used for preclinical and clinical research on tumor diseases such as skin T-cell lymphoma.
• As a high-purity standard or synthetic intermediate, it is used for basic research on drug metabolism and efficacy evaluation in domestic and foreign pharmaceutical research and development institutions.

Main Advantages

• Strong targeting 

Ritlecitinib powder is highly selective towards the JAK3 and TEC kinase families, with a much lower risk of off target adverse reactions compared to the first generation.

• Rapid onset

Short half-life (about 1.3-2.3 hours), fast clearance in the body, conducive to precise dosage regulation.

• Wide coverage

Patients aged 12 and above can use it, and the available population is wider than similar drugs.

Contact us sales1@faithfulbio.com or Whats App：+86 17782784795

Why choose us

Responsible for quality

• Quality is the foundation of a company. We always adhere to honest management, select high-quality products, and provide you with layers of quality control.

Serve partners

• We position ourselves as a reliable partner in your career development, rather than a simple supplier, always providing you with "professional and efficient" services and assistance.

Quality Control

R&D Results

Packaging and Transportation

After-Sales Service

Qualification Certification

Exhibition

FAQ

Q1:How it works?

A1:By inhibiting Janus kinase, Ritlecitinib can interfere with abnormal activity of the immune system, reduce inflammation in the immune response, and potentially alleviate symptoms caused by autoimmune diseases.

Q2:What is the main difference between Ritlecitinib and pan JAK inhibitors?

A2:Ritlecitinib is a specific JAK3/TEC covalent inhibitor with high selectivity for other subtypes such as JAK1 and JAK2, resulting in lower risk of adverse reactions and greater safety.

Q3:What are the adverse reactions of Ritlecitinib?

A3:Common adverse reactions (incidence ≥ 1%) include headache, diarrhea, acne, rash, urticaria, folliculitis, fever, atopic dermatitis, dizziness, elevated creatine kinase, herpes zoster, decreased red blood cell count, and stomatitis.

Contact US

 We have Ritlecitinib powder.  Contact us sales1@faithfulbio.com or Whats App：+86 17782784795 .